MXPA03002864A - Portafolios de pronostico de cancer de mama. - Google Patents

Portafolios de pronostico de cancer de mama.

Info

Publication number
MXPA03002864A
MXPA03002864A MXPA03002864A MXPA03002864A MXPA03002864A MX PA03002864 A MXPA03002864 A MX PA03002864A MX PA03002864 A MXPA03002864 A MX PA03002864A MX PA03002864 A MXPA03002864 A MX PA03002864A MX PA03002864 A MXPA03002864 A MX PA03002864A
Authority
MX
Mexico
Prior art keywords
breast cancer
genes
cancer prognostic
prognostic portfolio
portfolio
Prior art date
Application number
MXPA03002864A
Other languages
English (en)
Spanish (es)
Inventor
Yixin Wang
Original Assignee
Johnson & Johnson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=29215884&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MXPA03002864(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Johnson & Johnson filed Critical Johnson & Johnson
Publication of MXPA03002864A publication Critical patent/MXPA03002864A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
MXPA03002864A 2002-03-29 2003-03-31 Portafolios de pronostico de cancer de mama. MXPA03002864A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US36878902P 2002-03-29 2002-03-29

Publications (1)

Publication Number Publication Date
MXPA03002864A true MXPA03002864A (es) 2004-08-11

Family

ID=29215884

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03002864A MXPA03002864A (es) 2002-03-29 2003-03-31 Portafolios de pronostico de cancer de mama.

Country Status (11)

Country Link
US (1) US7473526B2 (https=)
EP (1) EP1367138B1 (https=)
JP (1) JP2003325192A (https=)
KR (1) KR20030078805A (https=)
CN (1) CN1495274A (https=)
AR (1) AR039213A1 (https=)
AU (1) AU2003203557B2 (https=)
BR (1) BR0303092A (https=)
CA (1) CA2422303A1 (https=)
DE (1) DE60317606T2 (https=)
MX (1) MXPA03002864A (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1361433A3 (en) * 2002-04-09 2005-02-23 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Method for estimating therapeutic efficacy of tumor necrosis factor (TNF)
US20050003422A1 (en) * 2003-07-01 2005-01-06 Mitch Reponi Methods for assessing and treating cancer
CA2556890C (en) * 2004-02-20 2017-04-25 Veridex, Llc Breast cancer prognostics
US20050244872A1 (en) * 2004-04-23 2005-11-03 Exagen Diagnostics, Inc. Breast cancer gene expression biomarkers
US20070130694A1 (en) * 2005-12-12 2007-06-14 Michaels Emily W Textile surface modification composition
WO2007088971A1 (ja) * 2006-02-03 2007-08-09 Messengerscape Co., Ltd. がん予後判定に利用できる遺伝子群
CN101631454A (zh) 2006-12-08 2010-01-20 衣阿华州立大学研究基金公司 参与硝酸盐吸收和代谢的植物基因
CN105224827B (zh) * 2008-07-01 2019-12-24 小利兰·斯坦福大学托管委员会 用于发展ivf治疗协议的分析数据的计算机系统和存储介质
ES2338843B1 (es) * 2008-07-02 2011-01-24 Centro De Investigaciones Energeticas, Medioambientales Y Tecnologicas Huella genomica de cancer de mama.
GB0821787D0 (en) * 2008-12-01 2009-01-07 Univ Ulster A genomic-based method of stratifying breast cancer patients
US8790916B2 (en) 2009-05-14 2014-07-29 Genestream, Inc. Microfluidic method and system for isolating particles from biological fluid
CA2818890C (en) 2010-11-23 2022-07-12 Krisani Biosciences (P) Ltd Method and system for prognosis and treatment of diseases using portfolio of genes
KR101287600B1 (ko) * 2011-01-04 2013-07-18 주식회사 젠큐릭스 초기유방암의 예후 예측용 유전자 및 이를 이용한 초기유방암의 예후예측 방법

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US635152A (en) * 1899-06-05 1899-10-17 Melancthon S Shotwell Car-body bolster.
US6350576B1 (en) * 1994-12-20 2002-02-26 Cold Spring Harbor Laboratory Cancer detection probes
EP1505159B1 (en) 1995-03-17 2008-05-28 John Wayne Cancer Institute Detection of breast metastases with a multiple marker assay
US6275814B1 (en) * 1996-11-27 2001-08-14 Investment Strategies Network Investment portfolio selection system and method
US6003018A (en) * 1998-03-27 1999-12-14 Michaud Partners Llp Portfolio optimization by means of resampled efficient frontiers
US6037129A (en) * 1998-05-28 2000-03-14 Medical University Of South Carolina Multi-marker RT-PCR panel for detecting metastatic breast cancer
US6175624B1 (en) * 1999-03-05 2001-01-16 Centurion International, Inc. Method for connecting a battery circuit in a cellular telephone
MXPA01009369A (es) 1999-03-15 2003-06-06 Eos Biotechnology Inc Nuevos metodos para el diagnostico del cancer colorectal, composiciones, y metodos para seleccionar moduladores del cancer colorectal.
CA2383592A1 (en) * 1999-03-31 2000-10-05 Curagen Corporation 2384891 acids including open reading frames encoding polypeptides; orfx
US6175824B1 (en) * 1999-07-14 2001-01-16 Chi Research, Inc. Method and apparatus for choosing a stock portfolio, based on patent indicators
US6353152B1 (en) * 1999-07-15 2002-03-05 Research Development Foundation Corticotropin releasing factor receptor 2 deficient mice and uses thereof
WO2003070889A2 (en) * 2002-02-19 2003-08-28 Idec Pharmaceuticals Corporation Prostate specific genes and the use thereof in design or therapeutics
US20050054826A1 (en) * 2003-05-19 2005-03-10 Rosetta Inpharmatics Llc Human diaphanous-3 gene and methods of use therefor

Also Published As

Publication number Publication date
DE60317606T2 (de) 2008-10-23
JP2003325192A (ja) 2003-11-18
EP1367138B1 (en) 2007-11-21
CN1495274A (zh) 2004-05-12
US20030190656A1 (en) 2003-10-09
CA2422303A1 (en) 2003-09-29
AU2003203557B2 (en) 2007-05-24
EP1367138A3 (en) 2004-03-10
AR039213A1 (es) 2005-02-09
DE60317606D1 (de) 2008-01-03
US7473526B2 (en) 2009-01-06
KR20030078805A (ko) 2003-10-08
EP1367138A2 (en) 2003-12-03
BR0303092A (pt) 2004-09-08
AU2003203557A1 (en) 2003-10-23

Similar Documents

Publication Publication Date Title
MXPA03002862A (es) Panel de diagnostico del cancer.
MXPA03002864A (es) Portafolios de pronostico de cancer de mama.
EP2230319A3 (en) Gene expression markers for breast cancer prognosis
WO2005100606A3 (en) Gene expression markers for predicting response to chemotherapy
WO2001094629A3 (en) Cancer gene determination and therapeutic screening using signature gene sets
AU2014899A (en) Metastatic breast and colon cancer regulated genes
AU2002316251A1 (en) Diagnosis and prognosis of breast cancer patients
EP1526186A3 (en) Colorectal cancer prognostics
MXPA04003931A (es) Pronostico de cancer de mama.
EP2333112A3 (en) Breast cancer prognostics
WO2004101764A3 (en) Methods of modulating metastasis and skeletal related events resulting from metastases
WO2004005883A3 (en) Secreted and cytoplasmic tumor endothelial markers
PT1058739E (pt) Metodo para produzir perfis de expressao genica
MXPA03002863A (es) Valoracion de cancer colorrectal.
WO2004090547A3 (en) Metastatic colorectal cancer signatures
MXPA03002866A (es) Valoracion de cancer colorrectal.
ATE256120T1 (de) Reagentien für cyp2d fluoreszenztest
IL126257A (en) Immuno-magnetic cell separation for use in identification of genes associated with site-preferenced cancer methastasis formation
BR0012301A (pt) Inibidores de crescimento de células epiteliais
ATE297409T1 (de) In krebszellen überexprimiertes genprodukt
DE69939623D1 (de) Polymorphe marker von prostatakarzinom tumorantigen-1 (pcta-1)
EP1023459A4 (en) DETERMINATION OF EXISTING QUANTITIES OF CYCLINE-DEPENDENT KINASE INHIBITOR P27 AS A PROGNOSTIC FACTOR IN CANCER PATIENTS
WO2005054510A3 (en) Predicting response and outcome of metastatic breast cancer anti-estrogen therapy
WO2001062964A3 (en) A genetic determinant for malignant melanoma

Legal Events

Date Code Title Description
FA Abandonment or withdrawal